NPS for Ischemic Stroke
(NITE1 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new device called the NOVIS Transcarotid Neuroprotection System for individuals who have experienced an ischemic stroke due to a blocked artery in the brain. The trial aims to determine if this device is safe and effective when other treatments, such as catheter-based methods through the groin, have failed. It suits those who have had a stroke in the front part of the brain and have not succeeded with other artery-clearing methods. As an unphased trial, it provides a unique opportunity to contribute to groundbreaking research and potentially benefit from an innovative treatment.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you are currently receiving IV tPA (a clot-busting medication), you would not be eligible for this trial.
What prior data suggests that the NOVIS Transcarotid Neuroprotection System is safe for transcarotid intervention?
Research has shown that the NOVIS Transcarotid Neuroprotection System (NPS) is generally safe for patients who have had strokes. Other studies have found that using NPS during stroke treatment carries a low risk of causing complications such as another stroke or heart issues afterward. In past uses, patients have tolerated the system well. The treatment aims to assist patients who haven't benefited from other stroke procedures, offering a safe and promising alternative.12345
Why are researchers excited about this trial?
Researchers are excited about the NOVIS Transcarotid Neuroprotection System (NPS) because it offers a novel approach to treating ischemic stroke, particularly in patients who have not benefited from traditional transfemoral endovascular therapy. Unlike standard treatments that generally involve accessing the brain's blood vessels through the femoral artery in the leg, the NOVIS system uses a transcarotid approach, directly accessing the carotid artery in the neck. This method may provide improved protection and efficiency in removing blockages in large vessel occlusions, potentially leading to better outcomes for patients who have anterior circulation strokes. This innovative delivery method could represent a significant advancement in stroke care, especially for those who have limited options after conventional treatments fail.
What evidence suggests that the NOVIS Transcarotid Neuroprotection System is effective for ischemic stroke?
Research has shown that the NOVIS Transcarotid Neuroprotection System (NPS), which trial participants will receive, protects the brain during certain strokes by reversing blood flow in the carotid artery. This method helps prevent further brain damage when standard treatments fail. Studies have found that this system is safe and practical for patients with sudden strokes. Results suggest that using the NOVIS system can reduce the risk of additional strokes and heart issues after the procedure. The device's unique approach to altering blood flow direction offers a promising new option for stroke patients who haven't benefited from other treatments.12346
Who Is on the Research Team?
Charles Matouk, MD
Principal Investigator
Yale University
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Patients receive the NOVIS Transcarotid Neuroprotection System treatment after failed transfemoral therapy for acute ischemic stroke
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of adverse events and functional independence
What Are the Treatments Tested in This Trial?
Interventions
- NOVIS Transcarotid Neuroprotection System
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Patients that have failed transfemoral endovascular therapy in the case of anterior circulation strokes due to large vessel embolic occlusions will enrolled in the study and treated using the NOVIS Transcarotid NPS.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Silk Road Medical
Lead Sponsor
Citations
NPS for Ischemic Stroke (NITE1 Trial)
This trial tests a new device that protects the brain by changing blood flow direction in patients with certain types of strokes who did not respond to ...
2.
studypages.com
studypages.com/s/acute-ischemic-stroke-treatment-study-using-the-novis-transcarotid-neuroprotection-system-887357/Acute Ischemic Stroke Treatment Study Using the NOVIS ...
The purpose of this study is to evaluate the safety and feasibility of the NOVIS Transcarotid NPS device when used for transcarotid mechanical thrombectomy.
Feasibility Study of the Treatment of Acute Ischemic Stroke ...
Study Objective is to establish the feasibility and safety of the NOVIS Transcarotid Neuroprotection System when used for the transcarotid ...
G200347-NCT04881162
Study Title. Feasibility Study of the Treatment of Acute Ischemic Stroke Using the NOVIS Transcarotid Neuroprotection System In Transcarotid Embolectomy.
Outcomes associated with a transcarotid artery ...
We report that dynamic reverse-flow TCAR using the ENPS continues to be safe, feasible, and efficacious with minimal risks of postoperative stroke, myocardial ...
Perioperative and 1‐Year Rates of Stroke or Death
TCAR appears to be a safe alternative to CEA and TF‐CAS when used selectively and may be useful when treating symptomatic patients.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.